Results 131 to 140 of about 13,032 (201)

TARGETING HUMAN MITOCHONDRIAL ClpP AS A NOVEL THERAPEUTIC APPROACH TO H3K27-ALTERED DIFFUSE MIDLINE GLIOMA

open access: yes
H3K27-altered diffuse midline glioma (DMG) is one of the most aggressive pediatric brain tumors, with a median overall survival of less than 12 months.
Morena Miciaccia   +10 more
core  

ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma. [PDF]

open access: yesNeuro Oncol
Tzaridis T   +14 more
europepmc   +1 more source

Repurposing Birabresib to target Gram‑positive bacteria. [PDF]

open access: yesNPJ Antimicrob Resist
Koly HK, Razzaq R, Hossain T, Butzin NC.
europepmc   +1 more source

Multi-ancestry colocalization approaches. [PDF]

open access: yesPLoS Genet
Shen C, Dupuis J, Zhang Q.
europepmc   +1 more source

Developing a library of HaloPROTACs targeting the ClpP protease

open access: yes
Proteolysis-targeting chimeras (PROTACs) have received recent attention as a new therapeutic agent that have the potential to have a great impact in drug discovery.
Nani, Alexandra
core  

Exercise elicits mitonuclear protein imbalance and UPR<sup>mt</sup> in the liver of mice with obesity. [PDF]

open access: yesJ Physiol Biochem
Rocha MB   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy